Dominique Velin

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


64 publications

2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1993 | 1991 | 1990 |
2022
 
A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota.
Messaoudene M., Pidgeon R., Richard C., Ponce M., Diop K., Benlaifaoui M., Nolin-Lapalme A., Cauchois F., Malo J., Belkaid W. et al., 2022/04/01. Cancer discovery, 12 (4) pp. 1070-1087. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_20DD01671E5B]
GM-CSF is key in the efficacy of vaccine-induced reduction of Helicobacter pylori infection.
Vaillant L., Oster P., McMillan B., Orozco Fernandez E., Velin D., 2022/04. Helicobacter, 27 (2) pp. e12875. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E9724186F668]
 
Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.
Oster P., Vaillant L., Riva E., McMillan B., Begka C., Truntzer C., Richard C., Leblond M.M., Messaoudene M., Machremi E. et al., 2022/03. Gut, 71 (3) pp. 457-466. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_142E8F1FCE05]
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
Tonneau M., Nolin-Lapalme A., Kazandjian S., Auclin E., Panasci J., Benlaifaoui M., Ponce M., Al-Saleh A., Belkaid W., Naimi S. et al., 2022. Oncoimmunology, 11 (1) p. 2096535. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D970B474B020]
The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection.
Oster P., Vaillant L., McMillan B., Velin D., 2022. Frontiers in immunology, 13 p. 899161. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A0B0F20EDD09]
2021
FOXC2 controls adult lymphatic endothelial specialization, function, and gut lymphatic barrier preventing multiorgan failure.
González-Loyola A., Bovay E., Kim J., Lozano T.W., Sabine A., Renevey F., Arroz-Madeira S., Rapin A., Wypych T.P., Rota G. et al., 2021/07. Science advances, 7 (29) pp. eabf4335. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3852082D8787]
 
Gastric eosinophils are detrimental for Helicobacter pylori vaccine efficacy.
Vaillant L., Oster P., McMillan B., Velin D., 2021/06/16. Vaccine, 39 (27) pp. 3590-3601. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_369D55787F13]
2020
Toll-Interacting Protein Regulates Immune Cell Infiltration and Promotes Colitis-Associated Cancer.
Begka C., Pattaroni C., Mooser C., Nancey S., Swiss IBD Cohort Study Group, McCoy K.D., Velin D., Maillard M.H., 2020/03/27. iScience, 23 (3) p. 100891. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9F4D29F09585]
2019
Maf deficiency in T cells dysregulates T<sub>reg</sub> - T<sub>H</sub>17 balance leading to spontaneous colitis.
Imbratta C., Leblond M.M., Bouzourène H., Speiser D.E., Velin D., Verdeil G., 2019/04/16. Scientific reports, 9 (1) p. 6135. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B94E063539E7]
2017
Mise au point sur la rectocolite ulcéro-hémorragique en 2017 [Management of ulcerative colitis in 2017]
Moschouri E., Hessler R., Pittet V., Velin D., Conrad C., Hahnloser D., Gié O., Michetti P., Schoepfer A.M., Maillard M.H., 2017/08/30. Revue medicale suisse, 13 (572) pp. 1480-1486. Peer-reviewed.
[URN][Pmid][serval:BIB_F34A824E37CF]
 
IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice.
Moyat M., Bouzourene H., Ouyang W., Iovanna J., Renauld J.C., Velin D., 2017/01. Mucosal immunology, 10 (1) pp. 271-281. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_240A0477B6D4]
2016
Tollip, an early regulator of the acute inflammatory response in the substantia nigra.
Humbert-Claude M., Duc D., Dwir D., Thieren L., Sandström von Tobel J., Begka C., Legueux F., Velin D., Maillard M.H., Do K.Q. et al., 2016/12/07. Journal of neuroinflammation, 13 (1) p. 303. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_637444BCA5E2]
 
Inflammation, immunity, and vaccines for Helicobacter pylori infection.
Velin D., Straubinger K., Gerhard M., 2016/09. Helicobacter, 21 Suppl 1 pp. 26-29. Peer-reviewed.
[DOI][Pmid][serval:BIB_8BC055D1BBD0]
 
Preventing Overheating: Tight Control of Gut Innate Immunity in Health and Disease.
Begka C., Velin D., Maillard M.H., 2016/07. Inflammatory bowel diseases, 22 (7) pp. 1723-1736. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5B64D6057C0C]
Use of VacA as a Vaccine Antigen.
Moyat M., Velin D., 2016. Toxins, 8 (6) pp. 725-730.
[URN][DOI][WoS][Pmid][serval:BIB_DA3D3F958980]
2015
Epithelial NAIPs protect against colonic tumorigenesis.
Allam R., Maillard M.H., Tardivel A., Chennupati V., Bega H., Yu C.W., Velin D., Schneider P., Maslowski K.M., 2015. Journal of Experimental Medicine, 212 (3) pp. 369-383.
[URN][DOI][WoS][Pmid][serval:BIB_B4563C30990A]
 
Role of Inflammatory Monocytes in Vaccine-Induced Reduction of Helicobacter felis Infection.
Moyat M., Mack M., Bouzourene H., Velin D., 2015. Infection and Immunity, 83 (11) pp. 4217-4228. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9253CD28D90D]
2014
 
Critical Role of the GM-CSF Signaling Pathway in Macrophage Pro-Repair Activities.
Bernasconi E., D'Angelo F., Michetti P., Velin D., 2014. Pathobiology, 81 (4) pp. 183-189. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7CB7F9E039C5]
 
Immune responses to Helicobacter pylori infection.
Moyat M., Velin D., 2014. World Journal of Gastroenterology, 20 (19) pp. 5583-5593. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA5DE749B3F7]
 
In vitro and in vivo Repair Activities of Undifferentiated and Classically and Alternatively Activated Macrophages.
Enderlin Vaz da Silva Z., Lehr H.A., Velin D., 2014. Pathobiology, 81 (2) pp. 86-93. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_61F3BB06DA50]
 
Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients.
Pittet V., Rogler G., Mottet C., Froehlich F., Michetti P., de Saussure P., Burnand B., Vader J.P., Swiss IBD Cohort Study Group*, 2014. Scandinavian Journal of Gastroenterology, 49 (6) pp. 662-673. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C0337252322D]
 
Toll-interacting protein modulates colitis susceptibility in mice.
Maillard M.H., Bega H., Uhlig H.H., Barnich N., Grandjean T., Chamaillard M., Michetti P., Velin D., 2014. Inflammatory Bowel Diseases, 20 (4) pp. 660-670.
[DOI][WoS][Pmid][serval:BIB_C66645FBCA5B]
2013
 
Effects of an interleukin-15 antagonist on systemic and skeletal alterations in mice with DSS-induced colitis.
Brounais-Le Royer B., Pierroz D.D., Velin D., Frossard C., Zheng X.X., Lehr H.A., Ferrari-Lacraz S., Ferrari S.L., 2013. American Journal of Pathology, 182 (6) pp. 2155-2167.
[DOI][WoS][Pmid][serval:BIB_871D8AD328E5]
Macrophages promote epithelial repair through hepatocyte growth factor secretion.
D'Angelo F., Bernasconi E., Schäfer M., Moyat M., Michetti P., Maillard M.H., Velin D., 2013. Clinical and Experimental Immunology, 174 (1) pp. 60-72. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7B92562F4EAF]
 
Maladie coeliaque: état des lieux [An update on celiac disease].
Godat S., Velin D., Aubert V., Nydegger A., Schoepfer A.M., Maillard M.H., 2013. Revue Médicale Suisse, 9 (396) pp. 1584-1589.
[Pmid][serval:BIB_68904038A189]
2012
 
PAR2 Promotes Vaccine-Induced Protection against Helicobacter Infection in Mice
Velin D., 2012. dans 10th International Workshop on Pathogenesis and Host Response in Helicobacter Infections.
[serval:BIB_32348202AC54]
 
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
Rieder F., Karrasch T., Ben-Horin S., Schirbel A., Ehehalt R., Wehkamp J., de Haar C., Velin D., Latella G., Scaldaferri F. et al., 2012. Journal of Crohn's and Colitis, 6 (3) pp. 373-385.
[DOI][WoS][Pmid][serval:BIB_3EEA6B6E20D9]
 
Toll-Interacting Protein Modulates Gut Flora Composition, Epithelial Barrier Integrity and Susceptibility to Colitis
Maillard M.H., Grandjean T., Uhlig H.H., Barnich N., Longet S., Corthésy B., Michetti P., Chamaillard M., Velin D., 2012. dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society of Visceral Surgery, Swiss Association of the Study of the Liver and Swiss Society of Clinical Nutrition, Swiss Medical Weekly.
[serval:BIB_8253C695E8CA]
 
Toll-Interacting-Protein Deficiency modulates flora composition and susceptibility to colitis
Maillard M.H., Chamaillard M., Uhlig H., Barnich N., Pythoud C., Bachmann D., Michetti P., Velin D., 2012. dans ICMI 2011, 15th International Congress of Mucosal Immunology. Peer-reviewed.
[serval:BIB_C1EEC462114D]
2011
 
Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis.
Favre Laurent, Borle François, Velin Dominique, Bachmann Daniel, Bouzourene Hanifa, Wagnieres Georges, van den Bergh Hubert, Ballabeni Pierluigi, Gabrecht Tanja, Michetti Pierre et al., 2011. Endoscopy, 43 (7) pp. 604-616. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5D5A35108330]
 
PAR2 Promotes Vaccine-Induced Protection Against Helicobacter Infection in Mice.
Velin D., Narayan S., Bernasconi E., Busso N., Ramelli G., Maillard M.H., Bachmann D., Pythoud C., Bouzourene H., Michetti P. et al., 2011. Gastroenterology, 141 (4) pp. 1273-1282.e1.
[DOI][WoS][Pmid][serval:BIB_A874E8A79624]
 
Pharmacological inhibition of interleukin-15 prevents colitis and associated bone loss in IL-10 knockout mice
Brounais-Le Royer B., Ferrari-Lacraz S., Velin D., Zheng X.X., Ferrari S.L., Pierroz D., 2011. pp. S237 dans 3rd Joint Meeting of the European Calcified Tissue Society and the International Bone and Mineral Society, Bone. Peer-reviewed.
[DOI][WoS][serval:BIB_2DEA5536D243]
2010
 
Advances in vaccination against Helicobacter pylori.
Velin D., Michetti P., 2010. Expert Review of Gastroenterology and Hepatology, 4 (2) pp. 157-166.
[DOI][WoS][Pmid][serval:BIB_8A4025718FA2]
 
Dysregulation of the Myeloid Cell Response Exacerbates Acute Colitis by Impairing Mucosal Healing
Bernasconi Eric, Maillard Michel H., D'Angelo Fabrizia, Bachmann Daniel, Pythoud Catherine, Bouzourene Hanifa, Schwendener Reto, Michetti Pierre, Velin Dominique, 2010. pp. 3S dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society for Visceral, Surgery Swiss Association for the Study of the Liver, Swiss Association of Clinical Nutrition, Swiss Medical Weekly. Peer-reviewed.
[WoS][serval:BIB_A49986663A6E]
 
Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing.
Bernasconi Eric, Favre Laurent, Maillard Michel H., Bachmann Daniel, Pythoud Catherine, Bouzourene Hanifa, Croze Ed, Velichko Sharlene, Parkinson John, Michetti Pierre et al., 2010. Inflammatory Bowel Diseases, 16 (3) pp. 428-441.
[DOI][WoS][Pmid][serval:BIB_A08162E98D74]
 
Macrophages from Crohn's disease patients exhibit deficient pro-repair functions
D'Angelo Fabrizia, Bernasconi Eric, Maillard Michel H., Andriamaha Catherine, Bachmann Daniel, Michetti Pierre, Velin Dominique, 2010. pp. 4S dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society for Visceral, Surgery Swiss Association for the Study of the Liver, Swiss Association of Clinical Nutrition, Swiss Medical Weekly. Peer-reviewed.
[WoS][serval:BIB_0D31A8AD8B38]
 
Role of Protease-activated receptor in vaccine-induced protection against Helicobacter infection
Velin Dominique, Narayan Sharma, Bernasconi Eric, Busso Nathalie, Ramelli Giancarlo, Maillard Michel H., Bachmann Daniel, Pythoud Catherine, Bouzourene Hanifa, Michetti Pierre et al., 2010. pp. 12S dans Annual meeting of the Swiss Society of Gastroenterology, Swiss Society for Visceral, Surgery Swiss Association for the Study of the Liver, Swiss Association of Clinical Nutrition, Swiss Medical Weekly. Peer-reviewed.
[WoS][serval:BIB_E7693D8CE053]
 
Toll-Interacting Protein Deficiency Leads to Increased Susceptibility to Acute and Chronic Colitis.
Maillard M., Bernasconil E., Holm U., Python C., Bachmann D., Bouzourene H., Burns K., Micheal P., Velinl D., 2010. pp. 7S dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society for Visceral, Surgery Swiss Association for the Study of the Liver, Swiss Association of Clinical Nutrition, Swiss Medical Weekly. Peer-reviewed.
[WoS][serval:BIB_C7A254085C05]
2009
 
Granulocyte macrophage colony stimulating factor improves mucosal repair in a mouse model of acute colitis (P278)
Bernasconi E, Favre L, Bachmann D, Bouzourene H, Croze E, Velischko S, Parkinson J, Michetti P, Velin D, 2009. pp. S120 dans 4th Congress of the European Crohn's and Colitis Organisation (ECCO), Journal of Crohn's and Colitis. Peer-reviewed.
[DOI][serval:BIB_F3642090CFD0]
 
Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model.
Velin D., Favre L., Bernasconi E., Bachmann D., Pythoud C., Saiji E., Bouzourene H., Michetti P., 2009. Gastroenterology, 136 (7) pp. 2237-2246.e1.
[DOI][WoS][Pmid][serval:BIB_B8197257B79B]
 
Patient irradiation during endoscopic retrograde cholangiopancreatography
Nichita C., Aroua A., Verdun F., Maerten P., Velin D., Ortner M., Michetti P.F., Dorta G.O., 2009. pp. 20S dans Annual meeting of the Swiss Society of Gastroenterology, Swiss Society for Visceral Surgery, Swiss Association for the Study of the Liver, Swiss Medical Weekly. Peer-reviewed.
[WoS][serval:BIB_564F47FABB17]
 
Patient irradiation during endoscopic retrograde cholangiopancreatography (ERCP) : P2080
Nichita C.M., Aroua A., Verdun F., Maerten P., Velin D., Ortner M., Michetti P.F., Dorta G.O.H., 2009. pp. A523 dans GASTRO 2009 UEGW/WCOG - UEGF (United European Gastroenterology Federation) and WGO (World Gastroenterology Organization), Gut.
[serval:BIB_D077CE1246E7]
 
Patient irradiation during endoscopic retrograde cholangiopancreatography (ERCP) : S1338
Nichita C., Aroua A., Verdun F., Maerten P., Velin D., Ortner M.A., Michetti P., Dorta G., 2009. pp. AB147 dans Annual Meeting of the American Society for Gastrointestinal Endoscopy, Digestive Disease Week, Gastrointestinal Endoscopy. Peer-reviewed.
[DOI][WoS][serval:BIB_48A7E48B647E]
2008
 
Reduction of Helicobacter infection in IL-10-/- mice is dependent on CD4+ T cells but not on mast cells.
Velin D., Bachmann D., Bouzourene H., Michetti P., 2008. Helicobacter, 13 (5) pp. 361-369.
[DOI][WoS][Pmid][serval:BIB_73FA4E405081]
2007
 
Expression of Helicobacter pylori virulence factors and associated expression profiles of inflammatory genes in the human gastric mucosa
Wen S., Velin D., Felley C. P., Du L., Michetti P., Pan-Hammarstrom Q., 2007/11. Infection and Immunity, 75 (11) pp. 5118-26.
[DOI][WoS][Pmid][serval:BIB_90B23DD9C33C]
2006
 
Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide
Didierlaurent A., Brissoni B., Velin D., Aebi N., Tardivel A., Kaslin E., Sirard J. C., Angelov G., Tschopp J., Burns K., 2006/02. Molecular and Cellular Biology, 26 (3) pp. 735-42.
[DOI][WoS][Pmid][serval:BIB_818669F18927]
 
Immunology of Helicobacter pylori infection
Velin D., Michetti P., 2006. Digestion, 73 (2-3) pp. 116-23.
[DOI][WoS][Pmid][serval:BIB_C4E20C20C31E]
2005
 
Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model
Velin D., Bachmann D., Bouzourene H., Michetti P., 2005/07. Gastroenterology, 129 (1) pp. 142-55.
[DOI][WoS][Pmid][serval:BIB_0C18B5EDBB1A]
2003
 
Expression of recombinant proteins in a lipid A mutant of Escherichia coli BL21 with a strongly reduced capacity to induce dendritic cell activation and maturation
Cognet I., de Coignac A. B., Magistrelli G., Jeannin P., Aubry J. P., Maisnier-Patin K., Caron G., Chevalier S., Humbert F., Nguyen T. et al., 2003/01. Journal of Immunological Methods, 272 (1-2) pp. 199-210.
[DOI][WoS][Pmid][serval:BIB_08B0147FD1F3]
 
Passive immunity in Helicobacter-challenged neonatal mice conferred by immunized dams lasts until weaning.
Corthésy-Theulaz I., Corthésy B., Bachmann D., Velin D., Kraehenbuhl J.P., 2003. Infection and Immunity, 71 (4) pp. 2226-2229.
[DOI][WoS][Pmid][serval:BIB_A5AD30D8F217]
 
Synthesis, refolding and protective immune responses of a potential antigen for human Respiratory Syncytial Virus vaccine.
Klinguer-Hamour C., Bussat M.C., Plotnicky H., Velin D., Corvaïa N., Nguyen T., Beck A., 2003. Journal of Peptide Research : Official Journal of the American Peptide Society, 62 (1) pp. 27-36. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_631CDC22AA0E]
2001
 
BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in mice
Goetsch L., Plotnicky-Gilquin H., Aubry J. P., De-Lys P., Haeuw J. F., Bonnefoy J. Y., Nguyen N. T., Corvaia N., Velin D., 2001/07. Vaccine, 19 (28-29) pp. 4036-42.
[DOI][WoS][Pmid][serval:BIB_699563EE8FA2]
 
Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigens
Klinguer C., Beck A., De-Lys P., Bussat M. C., Blaecke A., Derouet F., Bonnefoy J. Y., Nguyen T. N., Corvaia N., Velin D., 2001/07. Vaccine, 19 (30) pp. 4236-44.
[DOI][WoS][Pmid][serval:BIB_763A7CFE9293]
2000
 
Delivery systems and adjuvants for vaccination against HIV
Velin D., Kraehenbuhl J. P., 2000. EXS, 89 pp. 227-37.
[Pmid][serval:BIB_C0707493C4EF]
1999
 
Systemic antibodies can inhibit mouse mammary tumor virus-driven superantigen response in mucosa-associated lymphoid tissues.
Velin D., Fotopoulos G., Kraehenbuhl J.P., Acha-Orbea H., 1999. Journal of Virology, 73 (2) pp. 1729-1733. Peer-reviewed.
[WoS][Pmid][serval:BIB_9DFB88E54072]
1998
 
Delivery systems and adjuvants for vaccination against HIV.
Velin D., Hopkins S., Kraehenbuhl J., 1998. Pathobiology, 66 (3-4) pp. 170-175.
[DOI][WoS][Pmid][serval:BIB_8DD1A8EAB197]
1997
The nasal-associated lymphoid tissue of adult mice acts as an entry site for the mouse mammary tumor retrovirus.
Velin D., Fotopoulos G., Luthi F., Kraehenbuhl J.P., 1997. Journal of Experimental Medicine, 185 (10) pp. 1871-1876.
[URN][DOI][WoS][Pmid][serval:BIB_7329]
1996
 
The neonatal Fc receptor is not required for mucosal infection by mouse mammary tumor virus.
Velin D., Acha-Orbea H., Kraehenbuhl J.P., 1996. Journal of Virology, 70 (10) pp. 7250-7254.
[WoS][Pmid][serval:BIB_5262BFD48C80]
1995
 
Interactions of the scid or beige mutations with the viable motheaten mutation.
Dominique V., Francis L., 1995. Autoimmunity, 22 (4) pp. 199-207. Peer-reviewed.
[WoS][Pmid][serval:BIB_E4C8A9938930]
 
Serological abnormalities induced by engraftment of viable motheaten hematopoietic cells in nude beige recipients
Velin D., Kuntz L., Loor F., 1995. Autoimmunity, 20 (1) pp. 25-32.
[DOI][WoS][Pmid][serval:BIB_A925CD500463]
1993
 
gld and lpr hematopoietic cell transfers: common and different serological features of the C57BL/6 chimeras
Velin D., Goettelfinger P., Froidevaux S., Loor F., 1993/05. Cellular Immunology, 148 (2) pp. 331-45.
[DOI][WoS][Pmid][serval:BIB_A36182D6B4F5]
1991
 
Different nature of the proliferation defects of GLD, LPR and MEV C57BL/6 mouse lymphoid cells
Froidevaux S., Kuntz L., Velin D., Loor F., 1991. Autoimmunity, 10 (3) pp. 233-40.
[DOI][WoS][Pmid][serval:BIB_0FFFC3D2041F]
1990
 
Adoptive transfer of viable motheaten (mev) humoral autoimmunity: IgM to IgG switch of the hyperglobulinaemia in nude, beige recipient mice
Kuntz L., Pflumio F., Velin D., Loor F., 1990/11. Immunology, 71 (3) pp. 341-6.
[WoS][Pmid][serval:BIB_ED0B15F37A6C]
 
Adoptive transfer of viable motheaten humoral autoimmunity in cyclophosphamide-immunodepressed beige recipient mice
Kuntz L., Velin D., Pflumio F., Loor F., 1990/08. Immunology, 70 (4) pp. 520-6.
[WoS][Pmid][serval:BIB_F2A3F76EC7C0]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University